NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 100 filers reported holding NUVALENT INC in Q4 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,355 | +29.2% | 51,243 | +18.5% | 0.00% | 0.0% |
| Q2 2023 | $1,823 | +121.8% | 43,233 | +37.1% | 0.00% | – |
| Q1 2023 | $822 | -6.3% | 31,523 | +7.1% | 0.00% | – |
| Q4 2022 | $877 | -93.7% | 29,438 | +4005.7% | 0.00% | – |
| Q3 2022 | $14,000 | +27.3% | 717 | -15.4% | 0.00% | – |
| Q2 2022 | $11,000 | -73.2% | 848 | -71.5% | 0.00% | – |
| Q1 2022 | $41,000 | – | 2,976 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,341,024 | $436,140,000 | 8.51% |
| Fairmount Funds Management LLC | 914,614 | $20,625,000 | 7.50% |
| Bain Capital Life Sciences Investors, LLC | 3,428,014 | $77,302,000 | 4.80% |
| VR Adviser, LLC | 803,951 | $18,129,000 | 2.33% |
| Boxer Capital, LLC | 1,210,192 | $27,290,000 | 0.95% |
| BVF INC/IL | 448,512 | $10,114,000 | 0.40% |
| Avoro Capital Advisors LLC | 1,257,671 | $22,288,000 | 0.35% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,052,394 | $23,731,000 | 0.28% |
| Perceptive Advisors | 750,000 | $16,913,000 | 0.25% |
| Logos Global Management LP | 134,650 | $2,733,000 | 0.20% |